Jupiter Life Line Profit Dips Despite Revenue Growth

Jupiter Life Line Hospitals Ltd announced its third-quarter results for FY26, revealing a mixed financial performance. The multi-speciality hospital chain operator reported a 18.3% decrease in net profit, which fell to ₹42.5 crore compared to ₹52 crore in the same period last year. Despite the dip in profit, the company's revenue demonstrated steady growth, increasing by 9.8% year-on-year to reach ₹365.3 crore. This revenue increase was attributed to continued traction across its hospital operations.

Operationally, EBITDA saw a 9.7% rise, reaching ₹83.9 crore from ₹76.5 crore a year prior. However, the company's EBITDA margins remained unchanged at 23%, indicating stable cost management. This performance underscores a divergence where higher revenues and EBITDA did not translate into overall profit growth during the quarter. The company's stock also reflected this sentiment, closing lower on the NSE.